Looking ahead, the spatial biology landscape continues to evolve at a remarkable pace. At STOmics, our daily engagement with researchers worldwide gives us a clear view of the shifts defining the field. For any spatial omics service, staying aligned with these changes is crucial. The role of a spatial transcriptomics service provider is expanding from a technology vendor to a comprehensive scientific partner. Here, we outline five specific directions that are shaping the offerings and priorities of spatial omics service providers as we approach 2026.

Demand for True Multi-Omic Integration

The request for layered data from a single experiment is becoming standard. Scientists seek to correlate gene expression with protein abundance directly within a tissue's architecture. This drives the need for platforms that can deliver concurrent, spatially aligned transcriptomic and proteomic data. In response, our spatial omics service at STOmics is built on a foundational capability for this integration. Our platform allows for the simultaneous measurement of the whole transcriptome and proteome from a complete tissue section, providing a unified dataset that is more powerful than the sum of its parts.

Accelerating the Translational Research Pathway

Applications are moving decisively from basic research toward clinical and pharmaceutical development. This transition requires a spatial transcriptomics service provider to ensure exceptional data reproducibility, standardized protocols, and compatibility with archived clinical specimens. The technology must generate reliable insights that can support biomarker identification and therapeutic targeting. For our team, this trend validates the design of our Stereo-seq technology, which offers the large field of view and high resolution needed to analyze heterogeneous clinical samples effectively.

Rise of Accessible and Powerful Bioinformatics

The value of a spatial omics service is increasingly judged by the clarity of the results it delivers, not just the volume of raw data it produces. There is a growing emphasis on integrated, user-friendly software and analytical pipelines that demystify complex spatial datasets. Providers must help researchers visualize, interpret, and derive biological meaning without requiring deep computational expertise. We address this by pairing our sequencing services with dedicated analysis tools like SAW, ensuring every project we support includes a clear path from data generation to biological insight.

Focus on Workflow Standardization and Automation

To support broader adoption and more consistent results, the entire workflow—from sample preparation to imaging—is undergoing refinement. Researchers expect a spatial transcriptomics service provider to offer streamlined, robust kits and automated instruments that reduce technical variability and hands-on time. This trend is about enhancing reliability and scalability. Our approach includes providing complete reagent kits and instrumentation, such as the Go Optical imager, designed to create a more standardized and efficient process for every laboratory that uses our spatial omics service.

Expansion of Collaborative and Consortium-Scale Projects

Scientific progress in spatial biology is increasingly driven by large, collaborative efforts that pool resources and expertise. This shapes the services a provider must offer, emphasizing project support for complex, multi-site studies. A capable spatial transcriptomics service provider must be equipped to handle large project volumes, ensure data consistency across batches, and facilitate secure data sharing formats. Our history of forging international collaborations has prepared us for this scale, allowing us to contribute to consortium projects that accelerate discovery across institutions.

These five directions highlight a field maturing from novel technology to essential research infrastructure. For providers, the focus is on delivering integrated, robust, and insightful solutions that keep pace with scientific ambition. At STOmics, we see these trends as a blueprint for our continued development. By advancing our spatiotemporal multi-omics platform and supporting scientists through every step, we are committed to evolving as a spatial transcriptomics service provider that meets these future needs. We are ready to help the research community turn these 2026 trends into tangible discoveries.